778 |
CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA1 F |
CACNA1F |
AIED |
COD3 |
COD4 |
CORDX |
CORDX3 |
CSNB2 |
CSNB2A |
CSNBX2 |
Cav1.4 |
Cav1.4alpha1 |
JM8 |
JMC8 |
OA2 |
300110 |
1393 |
ENSG00000102001 |
OTTHUMG00000022703 |
O60840 |
CACNAF1 |
CAC1F_HUMAN |
Voltage-dependent L-type calcium channel subunit alpha-1F |
Voltage-gated calcium channel subunit alpha Cav1.4 |
VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL ALPHA-1F SUBUNIT (VOLTAGE- GATED CALCIUM CHANNEL ALPHA SUBUNIT CAV1.4). [SOURCE:UNIPROT/SWISSPROT;ACC:O60840] |
PA26010 |
Target Class | Transporters |
Target Subclass | TC:1.A.1.11.11 |
Initial Gene Query | Cav1.4 |
Counted Citations from 1950-2000 | 97 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | Ion_trans_dom |
Human Readable Name | ION CHANNEL |
Interpro Type | Domain |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Acc | IPR005821 |
Interpro Name | Ion transport domain |
Uniprot Status | Swiss-Prot |
Target Main Class | Transporters |
Target Subclass | Voltage_gated_ion_channels |
Target Subclass | Channels |
Transmembrane Helix Count | 20 |
Target Subclass | CalciumChannels |
Gene Biotype | PROTEIN_CODING |
ION CHANNEL |
DRUGGABLE GENOME |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
Trial Name | Clevelox |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
inhibitor (inhibitory) |
Trial Name | Verapamil,Calan, Covera-HS |
Novel drug target | Established target |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated calcium channel blocker |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated L-type calcium channel blocker |
CACNA1F | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
CACNA1F | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:1.A.1.11.11 |
O60840 | Uniprot Accession |
CAC1F_HUMAN | Uniprot Id |
CACNA1F | Gene Symbol |
Target Main Class | Transporters |
Target Subclass | Voltage_gated_ion_channels |
Target Subclass | Channels |
CAC1F_HUMAN | Uniprot Id |
O60840 | Uniprot Accession |
CACNA1F | Uniprot Gene Name |
Interpro Short Name | Ion_trans_dom |
Human Readable Name | ION CHANNEL |
Interpro Type | Domain |
ION CHANNEL, DRUGGABLE GENOME |
CACNA1F | Display Id |
VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL ALPHA-1F SUBUNIT (VOLTAGE- GATED CALCIUM CHANNEL ALPHA SUBUNIT CAV1.4). [SOURCE:UNIPROT/SWISSPROT;ACC:O60840] | Description |
ENSG00000102001 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
778 | Entrez Gene ID |
Initial Gene Query | Cav1.4 |
Counted Citations from 1950-2000 | 97 |
ION CHANNEL |
PA26010 | PharmGKB ID |
CACNAF1 | GENE_SYMBOL |
CACNA1F | GENE_SYMBOL |
Voltage-dependent L-type calcium channel subunit alpha-1F | UNIPROT |
ENSG00000102001 | Gene Symbol |
CACNA1F | Ensembl Id |
DRUGGABLE GENOME |
Voltage-dependent L-type calcium channel subunit alpha-1F | Gene Name |
O60840 | UniProt ID |
ION CHANNEL |